ATE225165T1 - Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel - Google Patents

Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel

Info

Publication number
ATE225165T1
ATE225165T1 AT96401604T AT96401604T ATE225165T1 AT E225165 T1 ATE225165 T1 AT E225165T1 AT 96401604 T AT96401604 T AT 96401604T AT 96401604 T AT96401604 T AT 96401604T AT E225165 T1 ATE225165 T1 AT E225165T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
digestive tract
low
polymer film
coated capsule
Prior art date
Application number
AT96401604T
Other languages
English (en)
Inventor
Harumi Hatano
Takahiro Ito
Takashi Ishibashi
Hiroyuki Yoshino
Masakazu Mizobe
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE225165T1 publication Critical patent/ATE225165T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96401604T 1995-07-20 1996-07-18 Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel ATE225165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18365595 1995-07-20

Publications (1)

Publication Number Publication Date
ATE225165T1 true ATE225165T1 (de) 2002-10-15

Family

ID=16139614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96401604T ATE225165T1 (de) 1995-07-20 1996-07-18 Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel

Country Status (13)

Country Link
US (1) US6309666B1 (de)
EP (1) EP0754452B1 (de)
KR (1) KR100389602B1 (de)
CN (1) CN1076964C (de)
AT (1) ATE225165T1 (de)
CA (1) CA2181502C (de)
DE (1) DE69624047T2 (de)
DK (1) DK0754452T3 (de)
ES (1) ES2184846T3 (de)
ID (1) ID17428A (de)
PT (1) PT754452E (de)
SG (1) SG80553A1 (de)
TW (1) TW514533B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ336924A (en) * 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
CA2320193A1 (en) 1998-02-10 1999-08-19 Welfide Corporation Controlled release preparation
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2000018396A1 (fr) * 1998-09-25 2000-04-06 Sankyo Company, Limited PREPARATIONS A BASE D'INHIBITEUR DE HMG-CoA
CN100358509C (zh) 1998-09-28 2008-01-02 沃纳-兰伯特公司 采用hpmc胶囊进行肠和结肠传递
JP2000247911A (ja) 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
WO2001002014A1 (fr) 1999-07-02 2001-01-11 Hisamitsu Pharmaceutical Co., Inc. Compositions medicamenteuses destinees au traitement du cancer colorectal
ATE392885T1 (de) * 2000-02-28 2008-05-15 Pharmakodex Ltd Verabreichungssystemen für oral anzuwendende arzneimittel
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
KR100838686B1 (ko) * 2000-06-16 2008-06-16 미쯔비시 웰 파마 가부시키가이샤 방출 ｐＨ 범위 및/또는 속도 제어 조성물
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
JP4031232B2 (ja) * 2001-11-09 2008-01-09 カプスゲル・ジャパン株式会社 新規カプセル
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US7320583B2 (en) * 2003-04-16 2008-01-22 Frito-Lay North America, Inc Apparatus and method for producing colored extruded food products
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
GB0320522D0 (en) 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
TW200539903A (en) 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
US20050283097A1 (en) * 2004-06-18 2005-12-22 Ultrastop Ltd. Devices and methodologies useful in non invasive termination of pregnancy
DE102004046102B4 (de) * 2004-09-23 2009-09-03 Mars Inc. Indikatorgranulat
GB0427456D0 (en) * 2004-12-15 2005-01-19 Phoqus Pharmaceuticals Ltd Formulation for production of capsule shells and capsules
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
TW200808380A (en) * 2006-02-21 2008-02-16 Shinetsu Chemical Co Enteric-coated preparation for site-specific delivery of drug to site within the small intestine
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
KR101569604B1 (ko) 2007-12-28 2015-11-16 임팩스 라보라토리즈, 인코포레이티드 레보도파 방출 제어형 제제 및 이의 용도
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010080730A2 (en) * 2009-01-09 2010-07-15 Mayo Foundation For Medical Education And Research Methods and materials for delivering bile acids
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN103153289B (zh) * 2010-08-25 2016-08-31 格兰特·鲁弗斯·斯柏林二世 改进型肠溶活性物质给药
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
WO2013035081A2 (de) 2011-09-07 2013-03-14 JÄNISCH, Melisa Optimale formulierung zur freisetzung eines wirkstoffes im dickdarm
DE102011082716A1 (de) * 2011-09-14 2013-03-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Indikatorelement mit einer von einer in kontakt zu bringenden substanz abhängigen farbgebung
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP3054929B1 (de) * 2013-10-07 2020-08-05 Impax Laboratories, LLC Mukoadhäsive levodopa-formulierungen mit gesteuerter freisetzung und/oder levodopa-ester und verwendungen davon
US10927190B2 (en) 2016-04-08 2021-02-23 Daicel Corporation Cellulose ester and molded article thereof
EP3485879A1 (de) * 2017-11-17 2019-05-22 Maat Pharma Orale pharmazeutische formulierung enthaltend bakterien
WO2019211419A1 (en) * 2018-05-03 2019-11-07 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract
EP3862022B1 (de) * 2018-10-02 2024-06-12 Qualicaps Co., Ltd. Hartkapsel mit verbesserter festigkeit und herstellungsverfahren dafür
KR102106244B1 (ko) * 2019-10-30 2020-05-04 한국광기술원 앵커를 구비하는 캡슐형 광역학 치료장치
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
WO2023174722A1 (en) * 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPS6299322A (ja) 1985-10-24 1987-05-08 Shinjiro Tsuji 硬カプセル剤の新しい剤形
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
DE68920880D1 (de) * 1988-07-18 1995-03-09 Yamasa Shoyu Kk 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva.
DK0425699T3 (da) * 1989-05-11 1994-11-21 Chugai Pharmaceutical Co Ltd Oralt præparat, der kan frigives i et passende område i tarmen
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JP3122478B2 (ja) 1991-02-19 2001-01-09 帝國製薬株式会社 下部消化管放出型経口製剤
JPH0624962A (ja) 1992-07-09 1994-02-01 Green Cross Corp:The 腸溶徐放性製剤
DE69225979T2 (de) 1992-08-13 1998-12-17 Teikoku Seiyaku Kk Orale zubereitung zur freisetzung im unteren verdauungstract
EP0667148B1 (de) 1992-11-06 2002-07-03 Hisamitsu Pharmaceutical Co., Inc. Perorale pharmazeutische zubereitung mit freisetzung im unteren verfdauungstrakt
JPH06256166A (ja) 1993-01-06 1994-09-13 ▲寛▼治 ▲高▼田 薬物放出制御製剤
JPH0710745A (ja) 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤

Also Published As

Publication number Publication date
DE69624047T2 (de) 2003-08-14
EP0754452B1 (de) 2002-10-02
KR100389602B1 (ko) 2003-09-29
CN1142944A (zh) 1997-02-19
ID17428A (id) 1997-12-24
SG80553A1 (en) 2001-05-22
DE69624047D1 (de) 2002-11-07
US6309666B1 (en) 2001-10-30
TW514533B (en) 2002-12-21
PT754452E (pt) 2003-02-28
MX9602863A (es) 1997-09-30
EP0754452A3 (de) 1998-01-21
CN1076964C (zh) 2002-01-02
EP0754452A2 (de) 1997-01-22
ES2184846T3 (es) 2003-04-16
DK0754452T3 (da) 2003-02-03
CA2181502A1 (en) 1997-01-21
KR970005279A (ko) 1997-02-19
CA2181502C (en) 2003-02-11

Similar Documents

Publication Publication Date Title
ATE225165T1 (de) Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
MX9500885A (es) Preparacion farmaceutica para administracion oral.
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DK0673645T3 (da) Farmaceutisk præparat til afgivelse af lægemidler i colon
DE69619668T2 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
BR0315142A (pt) Cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
ATE244002T1 (de) Pharmazeutische formulierung mit omeprazol
ATE238774T1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
EP1504758A3 (de) Formulierungen mit kontrollierter Abgabe überzogen mit wässrigen Dispersionen von Ethylcellulose.
DE3773070D1 (de) Arzneimittel mit verzoegerter freigabe in oraler dosisform.
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
ATE221771T1 (de) Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes
SE8803822D0 (sv) Novel dosage form
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
ATE104146T1 (de) Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs.
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0754452

Country of ref document: EP

REN Ceased due to non-payment of the annual fee